There have always been rumours. Shrugs. Frowns. Long, drawn breaths. Admission that they were smart, hard working, but….

On stage at the Cambridge House Extraordinary Future show a few months back, as part of my ‘Gauntlet’ event, where I gave six CEOs a public roughing up, I asked Ascent Industries (ASNT.C) CEO Philip Campbell ‘What took you so long’ in getting your cannabis licence?

When I asked the question, I got a look from him, picked up clearly by the cameras, as if to say, ‘oh bruh, you gonna do me like that?’

His answer was very honest. Security clearance issues. A government that didn’t like the old MMAR program and those taking part in it. They were “not making any progress so decided to look at other opportunities for our business.”

“In honesty, the reason that we were held up in security clearance is we had some experience operating in the previous licencing system that Health Canada has established.”

You can catch it for yourself here:

That’s about as much as we’re likely to hear about the ‘why’ Ascent was notified by Health Canada that the regulators of Canada’s cannabis industry aim to revoke the company’s grow and dealers licence, at least in the short term.

This news was released today, and it’s not pretty.

Health Canada has advised the responses were not satisfactory to lift the suspension and has issued a letter to Ascent that it intends to revoke Agrima’s licences. In turn, the company intends to exercise its right to be heard under the Cannabis Act and Cannabis Regulations in order to maintain its licences. Should the company not be successful in this hearing process, the licences could be revoked.

Why?

Health Canada’s review is focused on the period during which the company was privately held. Health Canada asserts that unauthorized activities with cannabis took place under the company’s ACMPR (Access to Cannabis for Medical Purposes Regulations) licence during this period.

Oof.

The situation has already cost Campbell, and Reid Parr and James Poelzer their jobs at the company and, likely, their ability to work in the sector in Canada.

And the news shredded ASNT stock, as you’d predict it would.

There’s no way to look on the bright side of this, other than to say it probably needed to happen. For too long, potential partners and even acquirers have enjoyed what Campbell, Parr and Poelzer have built, but been concerned about what might lie underneath. The stutter-step around their security clearance hadn’t been something they’d been able to shake.

And, frankly, rumours multiply, especially as a market cap grows. I’d certainly heard them, but when the company received its grow licence, and then it’s dealer’s licence, it appeared any penance that was to be paid for perceived transgressions in the early days had already been ponied up.

Perhaps not. Eventually, the rumours clearly got loud enough that they made it back to Health Canada, and the resignation of the founding three suggests there’s a better path for the company in seeing them off than trying to prove the allegations spurious.

SO WHERE TO FROM HERE?

As I see it, there are four paths forward, and none of them are great – but the strong likelihood is, ASNT will carry on from here.

Option 1: Fight it in a tribunal hearing and win, likely by showing that the transgressors are gone and the company proper is ready to rehab. If that’s successful, I can’t see Health Canada restoring those licences for many months, after the company has proved itself clean over a long period.

Option 2: Sell the Canadian facilities entirely to a company that will have little trouble re-licencing them. After all, Health Canada appears to take no issue with the facilities, just the people running them over the last few years. I’d be shocked if the company isn’t already fielding calls on this matter from potential buyers. That would leave the company focused on global operations, of which they have several.

Option 3: Shut the BC facilities, sell the pieces at home and overseas, and liquidate.

Option 4: Sell the entire company, which might not even be an option management chooses for themselves. As the share price of ASNT hits $0.20, the market cap lingers at a very tasty $50.4m right now. A takeover offer might not even need to be at a premium to be successful, considering the situation they’re in.

It’s a sad day, either way. The founders are good guys, and ridiculously smart. They’ve put years of their lives, and their heart and soul into making it a thing.

I’m talking to the interim CEO in a few hours and will update accordingly. For now, thoughts and prayers.

— Chris Parry

FULL DISCLOSURE: Ascent is an Equity.Guru marketing client.

Disclaimer: ALWAYS DO YOUR OWN RESEARCH and consult with a licensed investment professional before making an investment. This communication should not be used as a basis for making any investment.

Chris Parry is a two-time Webster Award winning journalist who has been featured in the pages of The Vancouver Sun, The Province, National Post, Spin, Hollywood Reporter, FHM, Stuff, and Stockhouse. He was the first business journalist to identify and focus on the move to marijuana as an investment opportunity, and started Equity.Guru as a venue for honest, no punches pulled coverage of the North American public markets.

According to Ascent’s website, Blair Jordan is listed as Ascent’s interim CEO. Mark Brown is not listed in their leadership team.
Their website has been updated as Campbell, Parr, and Poelzer are not listed.

Latest Inside Info

STANDARD LITHIUM CLOSES $11.39M OFFERING(SLL.V) Mar. 21, 2019 – Standard Lithium Ltd. has closed its previously announced bought-deal offering, including the partial exercise of the over-allotment option. A total of 11,390,500 units of the company were issued at a price of $1 per unit for gross proceeds of $11,390,500. Each unit is comprised of one common share and half ...×0

LEONOVUS GROSSES $2.2M FROM WARRANTS(LTV.V) March 21, 2019 – Leonovus Inc. has announced that since Sept. 30, 2018 it has received gross proceeds of $2,201,550 from the exercise of warrants prior to their expirations on Mar. 10 and Mar. 20. All warrants issued by the company that matured on Mar. 10 or Mar. 20, 2019 have now been exercised or expired. “Leonovus is ...×0

HARVEST ONE SHIPS TO SHOPPERS DRUG MART(HVT.V) Mar. 21, 2019 – Harvest One Cannabis Inc., through its wholly-owned subsidiary United Greeneries Ltd., announced that it has completed its first shipment to Shoppers Drug Mart of Satipharm-branded cannabis. In this first shipment under the terms of the supply agreement announced on Mar. 18, Harvest One through United Greeneries has provided Shoppers with SatiSilver ...×0

PACIFIC RIDGE UNVEILS 2019 SPIUS DRILL PLANS(PEX.V) Mar. 21, 2019 – Pacific Ridge Exploration Ltd. reports on a planned 1,250-metre drill program for its road accessible Spius copper porphyry prospect located 40 kilometres southwest of Merritt, British Columbia. The program is planned for June and will consist of four to six holes. The drilling will target copper soil anomalies supported by ...×0

GENESIS BUYS TRENHOLME SITE FROM TECTONIC(GIS.V) Mar. 21, 2019 – Genesis Metals Corp. has entered into a binding purchase and sale agreement to acquire a 100 percent interest in the Trenholme property from Les Ressources Tectonic Inc. The property is located six kilometres to the northwest of the company’s Chevrier gold project near Chibougamau, Quebec. The property is comprised of 29 ...×0